Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

Iron-Containing Supplement, Drug Unit-Dose Packaging Rule Invalid – Court

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

FDA's reliance on current Good Manufacturing Practice regulations under the FD&C Act to justify requirement of unit-dose packaging for iron-containing dietary supplements and drugs is "misplaced," a New York federal appeals court concludes

You may also be interested in...



Package Certification Law Bears Down On Vitamins As Trade Groups Scramble

Vitamin supplement makers are adjusting begrudgingly to a certification requirement affecting packaging for products containing a certain amount of iron

Package Certification Law Bears Down On Vitamins As Trade Groups Scramble

Vitamin supplement makers are adjusting begrudgingly to a certification requirement affecting packaging for products containing a certain amount of iron

Package Certification Law Bears Down On Vitamins As Trade Groups Scramble

Vitamin supplement makers are adjusting begrudgingly to a certification requirement affecting packaging for products containing a certain amount of iron

Table

View full table

Related Content

HBW Insight
Pink Sheet
Pink Sheet

Topics

Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By